The warnings are coming from people who once worked inside the agency itself. Former Environmental Protection Agency scientists and officials say political pressure is increasingly shaping decisions about toxic chemicals, raising concerns that scientific findings could be taking a back seat to political and economic considerations.
A growing dispute inside the U.S. Environmental Protection Agency is shining a spotlight on how the federal government evaluates chemicals that millions of Americans encounter every day.
According to CNN, current and former EPA officials have expressed concern that political appointees in the Trump administration are playing a larger role in decisions traditionally guided by career scientists. The concerns center on chemical safety reviews, which help determine whether substances used in manufacturing, agriculture, consumer products and industrial operations pose risks to human health.
The issue has become increasingly sensitive because these reviews often form the scientific foundation for environmental regulations, workplace safety standards and public health protections.
For years, many of those assessments were handled by scientists within the EPA’s Integrated Risk Information System, commonly known as IRIS. The program’s findings have been used by federal agencies, state governments and regulators around the world when setting limits for exposure to hazardous chemicals.
Now, some former agency officials fear those scientific conclusions are facing growing political scrutiny.
An internal EPA directive reported earlier this year questioned the reliability of hundreds of existing chemical assessments and instructed agency offices to review regulations that relied on them. Environmental advocates and former regulators argued that such moves could weaken long-standing protections involving toxic substances ranging from arsenic to industrial pollutants.
At stake is not merely one regulation or one chemical. The debate is about who ultimately gets the final word when science and politics collide.
The Trump administration has rejected accusations that it is sidelining science.
EPA leadership has argued that regulatory decisions should balance scientific findings with economic impacts, legal considerations and broader policy objectives. Officials say oversight by political leadership is a normal part of government decision making and helps ensure regulations are practical and legally defensible.
Supporters of the administration also contend that previous chemical assessments sometimes overstated risks and imposed unnecessary costs on businesses and industries.
Critics see a different picture.
Former EPA scientists and environmental organizations argue that weakening scientific independence could leave dangerous chemicals in use for longer periods and make it harder to strengthen protections when new evidence emerges. Several recent disputes involving PFAS, often called “forever chemicals,” have intensified those concerns. The administration has proposed repealing or delaying some Biden-era limits on certain PFAS compounds in drinking water, prompting criticism from health advocates and environmental groups.
The controversy extends beyond PFAS.
Environmental groups have also raised concerns about regulatory reviews involving formaldehyde, ethylene oxide and other substances linked to cancer and other health risks. Critics argue that some recent policy shifts appear to favor industry concerns over precautionary health protections.
Former officials interviewed by CNN said they worry that scientists inside the agency may increasingly find themselves under pressure when their conclusions conflict with political priorities.
Those concerns echo broader debates that have surfaced repeatedly across multiple administrations about the role of science in government. But critics argue the current dispute is particularly important because chemical regulations often affect issues that people rarely see directly, including drinking water quality, air pollution standards, food contamination risks and exposure to toxic substances in everyday products.
The consequences of these decisions are often invisible until years later, when health studies begin linking illnesses, cancers or environmental damage to chemicals that were once considered safe.
Industry groups, meanwhile, have generally welcomed efforts to reexamine existing regulations, arguing that businesses deserve fair treatment and that agencies should avoid relying on overly conservative assumptions when assessing risk.
The debate is unlikely to fade anytime soon.
Environmental organizations are already preparing legal challenges to some EPA actions, while lawmakers and advocacy groups continue demanding greater transparency in how chemical safety decisions are made. At the same time, administration officials insist their approach reflects responsible governance rather than political interference.
As the fight continues, the EPA finds itself at the center of a larger national conversation about trust in scientific institutions, the limits of regulatory authority and the balance between public health protections and economic priorities.
For supporters of stronger oversight, political involvement ensures accountability.
For critics, it threatens the independence of scientific expertise that has long served as the backbone of environmental regulation in the United States.
